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Objectives The aim of this study was to estimate the annual incidence rate of sudden cardiac death (SCD) and to identify
risk factors for SCD in post-menopausal women.
Background With the aging U.S. population, post-menopausal women now have the greatest population burden of cardiovas-
cular disease including SCD.
Methods We examined 161,808 women who participated in the Women’s Health Initiative clinical trials and observa-
tional study. The women were recruited at 40 clinical sites across the United States, enrolled between 1993 and
1998, and followed until August 2009. Our primary endpoint is incident SCD, defined as death occurring within
1 h of symptom onset or within 1 h after the participant was last seen without symptoms and death that oc-
curred in the absence of a potentially lethal non-coronary disease process.
Results Four hundred eighteen women experienced adjudicated SCD. The incidence rate of SCD was 2.4/10,000 wom-
en/year (95% confidence interval: 2.2 to 2.7). We identified the following independent risk factors for SCD: older
age, African-American race, tobacco use, higher pulse, higher waist-to-hip ratio, elevated white blood cell
count, history of heart failure, diabetes, history of myocardial infarction, previous carotid artery disease,
and hypertension. Population-attributable fractions were greatest for hypertension, waist-to-hip ratio, and
myocardial infarction.
Conclusions Besides traditional risk factors for coronary heart disease, risk factors for sudden cardiac death in post-
menopausal women include African-American race, higher pulse, higher waist-to-hip ratio, elevated white blood
cell count, and heart failure. Nearly one-half of women who experienced sudden cardiac death had no previ-
ous diagnosis of coronary heart disease. (J Am Coll Cardiol 2012;60:2674–82) © 2012 by the American
College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.09.031Our understanding of the etiology and risk factors for
sudden cardiac death (SCD) is limited compared with other
acute cardiovascular events such as myocardial infarction
(MI) and stroke. It is also difficult to study because of
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Sudden cardiac death affects approximately 300,000 to
350,000 Americans each year (1–5) with an estimated
annual incidence of 0.1 to 0.2% (6). Although SCD is less
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SCD accounts for 13% of natural deaths (6) and one-half of
all coronary deaths (7), the leading cause of death in
Americans (8).
Post-menopausal women now have the greatest popula-
tion burden of cardiovascular disease, including SCD (9).
Yet the etiology of SCD in women is less clear, because
women are underrepresented in studies of SCD, and they
experience fewer SCD events than men. Several studies
suggest that pre-existing coronary disease is less predictive
in women, and other etiologies are more likely (5,10–12).
Sudden cardiac death trends over time also differ according
to sex: SCD death rates decreased faster in men compared
with women in all age groups between 1989 and 1998 (2).
The objectives of this paper are to estimate the annual
incidence rate of SCD in post-menopausal women; identify
sociodemographic, physiological, traditional, medical, and
behavioral risk factors for SCD in women; and determine
population-attributable fractions for SCD risk factors.
Methods
Study participants. The Women’s Health Initiative
(WHI) includes 161,808 study participants at 40 study sites
across the United States. Women participating in the
observational study (OS) numbered 93,676; and 68,132
participated in 1 or more of the 3 clinical trials (hormone
replacement therapy, calcium and vitamin D, and dietary
modification) (13). These interventions have been described
in detail previously (14). Briefly, the calcium and vitamin D
trial randomized women to receive calcium and vitamin D
supplements or a placebo. The dietary modification trial
randomized women to follow a low-fat, high fruit, vegeta-
ble, and grain diet or their usual eating pattern (control
subjects). The hormone therapy trial randomized women to
receive an estrogen-alone pill, an estrogen plus progestin
pill, or placebo. All women were post-menopausal and 50 to
79 years of age at baseline. Women who did not provide
written informed consent, did not plan to reside in the study
recruitment area for at least 3 years, had medical conditions
predictive of a survival time of 3 years, had characteristics
inconsistent with study compliance (alcoholism, drug de-
pendency, mental illness, dementia), or who were actively
participating in another controlled trial were excluded from
the OS and clinical trials. Other exclusion criteria were used
for each of the trials as described previously (14). Women
enrolled between 1993 and 1998 and were followed until
August 2009. We included all WHI participants in the OS
and in the control and intervention arms of the randomized
trials in our analyses.
Predictors. Sociodemographic variables and traditional
coronary heart disease (CHD) risk factors were measured by
self-report at baseline with standardized questionnaires
(age, race, income, marital status, education, smoking sta-
tus, family history of MI, physical activity [total metabolic
equivalents/week], multivitamin use, lifetime hormone use,comorbidities/disease history,
and medication use) as well as by
trained certified staff at the base-
line exam (height, weight, body
mass index [BMI], waist-to-hip
ratio, blood pressure, and pulse).
After women sat quietly for 5
min, blood pressure was mea-
sured with a mercury manometer
twice, 30 s apart, and the average
was used in this analysis. At
baseline, participants addition-
ally reported their diet with a
validated food frequency ques-
tionnaire (15) designed specifi-
cally for this population of post-
menopausal women. White
blood cell count (WBC) was
measured via standardized auto-
mated technique on fresh sam-
ples at each local WHI site. We
chose to categorize WBC with a cutpoint of 6.7 Kcell/ml on
the basis of findings that a WBC above 6.7 Kcell/ml might
distinguish individuals who are at a high risk of cardiovas-
cular events (16). Drugs that prolong the QT-interval were
defined according to Zipes et al. (6).
At baseline, participants were considered to have a
medical condition if they self-reported a physician diagnosis
at baseline and were also using drugs for that condition.
Prior CHD (excluding MI) included participants with a
history of the following at baseline: cardiac arrest, coronary
bypass surgery (CABG), angioplasty of coronary arteries
(PTCA), or angina. For our multivariable time-varying
exposure models, prior CHD (excluding MI) included the
aforementioned in addition to adjudicated CABG, adjudi-
cated PTCA, or adjudicated angina during follow-up. We
excluded MI from our definition of CHD, because after
looking at the individual components of CHD (cardiac
arrest, CABG, PTCA, angina, revascularization, and MI),
MI seemed to be the most important component and
therefore was interesting to consider on its own.
Carotid artery disease was defined as baseline self-report
of physician diagnosis or adjudicated carotid artery disease
during follow-up. Diabetes was defined as self-report of
physician diagnosis and taking medication at baseline or
self-report of treated diabetes during follow-up (nonadjudi-
cated). Hypertension was defined as systolic blood pressure
140 mm Hg or diastolic blood pressure 90 mm Hg or
using antihypertension medication during follow-up (self-
reported). Participants were asked to bring all of their
prescription medications to their baseline visit. These med-
ications were entered into a pharmacy database (Master
Drug Database, Medi-Span), and this database was used to
identify participants using various medications.
To determine who developed a medical condition or
Abbreviations
and Acronyms
BMI  body mass index
CABG  coronary artery
bypass surgery
CHD  coronary heart
disease
CI  confidence interval
HF  heart failure
HR  hazard ratio
MI  myocardial infarction
OS  observational study
PTCA  percutaneous
transluminal coronary
angioplasty
SCD  sudden cardiac
death
WBC  white blood cell
countdisease during follow-up, participants reported emergency
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SCD
(n  418)
No Cardiac Death
(n  159,873) p Value
Sociodemographic
Age at screening, yrs 68.0 6.6 63.2 7.2 0.01
Race 0.01
American Indian/Alaska Native 3 0.7% 700 0.4%
Asian/Pacific Islander 8 1.9% 4,160 2.6%
Black 61 14.6% 14,385 9.0%
Hispanic 7 1.7% 6,449 4.0%
White not of Hispanic origin 333 79.9% 131,947 82.7%
Not any of the above 5 1.2% 1,826 1.2%
Family Income 0.01
$20,000 120 30.5% 24,817 16.6%
$20,000–$74,999 243 61.7% 96,466 64.7%
$75,000 or more 31 7.9% 27,851 18.7%
Smoking status 0.01
Never or past smoker 354 86.3% 146,893 93.1%
Current smoker 56 13.7% 10,901 6.9%
Marital status 0.01
Married/marriage-like relationship 195 47.0% 99,398 62.5%
Never married/divorced/separated/widowed 220 53.0% 59,717 37.5%
Education 0.01
High school 34 8.2% 8,447 5.3%
High school 88 21.1% 27,253 17.2%
Some college 166 39.8% 60,143 37.9%
College graduate 129 30.9% 62,828 39.6%
Physiological
BMI, kg/m2 29.7 6.8 28.0 5.9 0.01
Waist, cm 93.0 15.6 86.4 13.8 0.01
Waist/hip ratio 0.01
Quartile 1: 0.28–0.76 52 12.4% 40,764 25.5%
Quartile 2: 0.77–0.80 62 14.8% 39,928 25.0%
Quartile 3: 0.81–0.86 106 25.4% 39,879 24.9%
Quartile 4: 0.87–2.88 198 47.4% 39,302 24.6%
Resting pulse in 60 s 71.9 14.2 69.6 12.1 0.01
WBC 6.7 Kcell/ml 190 45.5% 43,083 27.0% 0.01
Systolic blood pressure 0.01
120 mm Hg 90 21.6% 61,761 38.7%
120–140 mm Hg 189 45.3% 65,205 40.8%
140 mm Hg 138 33.1% 32,783 20.5%
Diastolic blood pressure 0.49
90 mm Hg 385 92.3% 148,812 93.2%
90 mm Hg 32 7.7% 10,908 6.8%
Behavioral
Dietary total fat (g) 62.4 62.2 60.6 35.6 0.55
Dietary alcohol (g) 4.5 12.4 5.2 10.5 0.32
Use a multivitamin 151 36.1% 62,321 39.0% 0.23
Total MET-h/week 9.6 12.0 12.5 13.8 0.01
Traditional
Maternal family history of MI 94 22.5% 28,630 17.9% 0.01
Paternal family history of MI 122 29.2% 45,747 28.6% 0.80
Diabetes 67 16.0% 5,382 3.4% 0.01
High cholesterol 57 14.6% 12,703 8.4% 0.01
Hypertension 213 52.3% 40,160 25.3% 0.01continued on the next page
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coronary revascularization procedures every 6 months in the
clinical trials and annually in the OS. Medical records for
overnight hospital stays and outpatient coronary revascular-
ization procedures were scrutinized for potential outcomes
of interest. Centrally or locally trained physician adjudica-
tors classified outcomes by reviewing medical records (17).
Outcome measurement. Medical records for all deaths
were scrutinized for potential outcomes of interest. Deaths
caused by coronary disease were confirmed on the basis of
death certificates, autopsy reports, circumstances of death,
electrocardiogram, laboratory test results, and reports from
all relevant procedures. Centrally or locally trained physician
adjudicators classified outcomes by reviewing medical re-
cords (17). Our primary endpoint was SCD, which was
ContinuedTable 1 Continued
Medical care
Have current health care provider 39
Hormone use
Never used 17
Past user 10
Current user 12
Comorbid (history at baseline)
Deep vein thrombosis 1
Pulmonary embolism 1
Stroke 2
Transient ischemic attack 3
MI 5
Any prior CHD (including MI) 9
Cardiac arrest
Congestive heart failure 2
Coronary bypass surgery 2
Angioplasty of coronary arteries 2
Carotid endarterectomy/angioplasty 1
Atrial fibrillation 4
Angina 7
Peripheral arterial disease 2
Rheumatoid arthritis 3
Drug use (at baseline)
Aspirin 13
Antidepressants 3
Lipid lowering medications 6
Blood pressure medications 24
Beta-blockers 6
Diuretics 19
ACE inhibitors/ARBs 16
Calcium channel blockers 14
Diabetes medications 6
Drugs that prolong QT interval 1
Psychosocial
Optimism construct score 2
Hostility construct score
Values are mean SD or n (%). Blood pressure medications include
ACE  angiotensin-converting-enzyme; ARB  angiotensin recepto
metabolic equivalents; MI  myocardial infarction; SCD  sudden cadefined as death occurring within 1 h of symptom onset orwithin 1 h after the participant was last seen without
symptoms, and death that occurred in the absence of a
potentially lethal non-coronary disease process. The medical
record or interview of witnesses had to document that
patient collapse was directly observed, as by hospital notes
and cardiopulmonary resuscitation records or by a relative or
observer clearly reporting that the patient was found unre-
sponsive within 60 min from previous direct observation
of stable clinical status. We included in-hospital and out-
of-hospital SCDs. We excluded cases of nonsudden coro-
nary death (death that occurs more than 1 h after symptom
onset) from our analyses (n  1,517).
Statistical analysis. Means and proportions of traditional
CHD risk factors and other baseline covariates were com-
pared by SCD status to determine risk factors for SCD in
SCD
 418)
No Cardiac Death
(n  159,873) p Value
96.1% 148,417 93.8% 0.04
0.01
43.7% 51,835 33.4%
26.7% 35,983 23.2%
29.6% 67,475 43.5%
4.1% 5,386 3.4% 0.43
2.4% 1,392 0.9% 0.01
5.7% 2,054 1.3% 0.01
7.4% 3,382 2.1% 0.01
12.7% 3,439 2.2% 0.01
22.7% 10,743 6.7% 0.01
1.2% 500 0.3% 0.01
6.7% 1,400 0.9% 0.01
6.4% 1,218 0.8% 0.01
5.9% 1,578 1.0% 0.01
2.5% 448 0.3% 0.01
11.3% 6,863 4.4% 0.01
17.3% 8,550 5.4% 0.01
6.5% 3,106 2.0% 0.01
7.4% 7,690 4.8% 0.01
31.3% 34,197 21.4% 0.01
8.9% 11,324 7.1% 0.16
15.1% 13,870 8.7% 0.01
59.1% 48,080 30.1% 0.01
15.1% 12,605 7.9% 0.01
46.2% 40,752 25.5% 0.01
38.5% 32,361 20.2% 0.01
35.7% 25,218 15.8% 0.01
16.3% 5,649 3.5% 0.01
3.4% 4,631 2.9% 0.58
3.5% 23 3.4% 0.01
3.0% 4 2.8% 0.01
ertensives, calcium channel blockers, beta-blockers, and diuretics.
er; BMI  body mass index; CHD  coronary heart disease; MET 
ath; WBC  white blood cell count.(n
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hi-square test for categorical variables. The list of potential
isk factors was developed on the basis of previous knowl-
dge and existing published reports. We used backward
limination (p  0.05), due to the large number of risk
actors, forcing age, race, prior CHD (excluding MI),
rior HF, and atrial fibrillation into our Cox proportional
azard model to determine what covariates to use in our
nal multivariable model (Table 2). Variables were in-
luded in the selection model if they were a significant
isk factor for SCD (crude hazard ratio [HR] parameter
value 0.2).
We checked multicollinearity with the variance inflation
actors from a linear regression model including all covari-
tes/predictors and with height as the dependent variable.
o variance inflation factors were 1.3. The final model
Table 2) used a time-varying analysis where the following
edical conditions/diseases were allowed to vary over time:
HD (excluding MI), heart failure, diabetes, MI, carotid
Multivariable Adjusted HRs and 95% CIs for SCDTable 2 Multivariable Adjusted HRs and 95% CIs for SCD
HR 95% CI p Trend
Sociodemographic
Age 1.09 1.07–1.11
Race
White 1.0 (ref)
African-American 1.61 1.18–2.19
Latino 0.73 0.32–1.64
Not any of the above 1.19 0.69–2.03
Total family income
$20,000 1.42 0.91–2.21
$20,000–$75,000 1.42 0.95–2.13
$75,000 1.0 (ref)
Smoking
Former/never smoker 1.0 (ref)
Current smoker 2.26 1.66–3.09
Physiological
Resting pulse (in 60 s) 1.01 1.00–1.02
BMI (kg/m2)
Normal (18.5 BMI 25) 1.0 (ref) 0.35
Overweight (25 BMI 30) 1.00 0.75–1.33
Obese (BMI 30) 1.15 0.86–1.56
Waist-to-hip ratio
Quartile 1 (0.76) 1.0 (ref) 0.01
Quartile 2 (0.77–0.80) 0.90 0.60–1.35
Quartile 3 (0.81–0.86) 1.23 0.85–1.78
Quartile 4 (0.87) 1.73 1.20–2.48
WBC 6.7 Kcell/ml 1.44 1.16–1.79
Disease history
CHD (excluding MI) 1.03 0.77–1.39
MI 4.71 3.48–6.36
Heart failure 3.51 2.67–4.69
Self-reported atrial fibrillation 1.25 0.88–1.75
Diabetes mellitus 2.00 1.55–2.58
Carotid artery disease 1.72 1.03–2.87
Hypertension 1.46 1.11–1.93f
Adjusted for all variables in the table.
CI  confidence interval; HR  hazard ratio; other abbreviations as in Table 1.rtery disease, and hypertension (18). Because SCD is
elatively rare, we combined the WHI clinical trial and obser-
ational cohorts to get stable estimates of the HRs of potential
CD risk factors. However, because the inclusion criteria were
ifferent for the clinical trial and observational cohorts, we used
nverse probability weighting to account for potential selection
ias when combining the clinical trial and OS into a single
nalytic cohort (18). We conducted a sensitivity analysis by
xcluding participants who reported a history of CHD (includ-
ng MI) at baseline or developed CHD during follow-up
Table 3) to see whether traditional CHD risk factors have a
ifferent impact on risk of SCD in this subgroup.
We only reported SCD estimates for white and African-
merican races, because there were very few SCD events for
he other race groups, which precluded calculating stable
stimates (Figs. 1A and 1B). Age-standardized rates were
alculated on the basis of the 2000 U.S. Census. Incidence
ate confidence intervals (CIs) were based on the following
Multivariable Adjusted HRs and 95%CIs for SCD Among Women Without Prior CHDTable 3 Multivariable Adjusted HRs and 95%CIs for SCD Among Women Without Prior CHD
HR 95% CI p-Trend
Sociodemographic
Age 1.11 1.08 1.13
Race
White 1.0 (ref)
African-American 1.34 0.87 2.08
Latino 0.87 0.36 2.14
Not any of the above 1.20 0.61 2.36
Total family income
$20,000 1.70 0.96 2.99
$20,000–$75,000 1.61 0.97 2.67
$75,000 1.0 (ref)
Smoking
Former/never smoker 1.0 (ref)
Current smoker 3.12 2.12 4.60
Physiological
Resting pulse (in 60 s) 1.00 0.99 1.01
BMI (Kg/m2)
Normal (18.5 BMI 25) 1.0 (ref) 0.27
Overweight (25 BMI 30) 1.06 0.73 1.52
Obese (BMI 30) 1.21 0.82 1.78
Waist-to-hip ratio
Quartile 1 (0.76) 1.0 (ref) 0.01
Quartile 2 (0.77–0.80) 1.05 0.63 1.75
Quartile 3 (0.81–0.86) 1.68 1.05 2.70
Quartile 4 (0.87) 2.02 1.26 3.24
WBC 6.7 Kcell/ml 1.38 1.04 1.83
Disease history
Heart failure 3.03 1.70 5.38
Self-reported atrial fibrillation 1.39 0.80 2.40
Diabetes mellitus 2.20 1.55 3.14
Carotid artery disease 2.75 1.21 6.25
Hypertension 1.55 1.12 2.14
Multivariable adjusted HRs and 95% CIs for SCD among women without prior CHD (including MI)
(n  169 events). Adjusted for all variables in the table.
Abbreviations as in Tables 1 and 2.ormula: estimated rate  1.96  (estimated rate  n
P2679JACC Vol. 60, No. 25, 2012 Bertoia et al.
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website (19). We calculated population-attributable frac-
tions on the basis of the following formula: [Pe(RR  1)/
e(RR 1)	1], where Pe is the prevalence of the exposure,
and relative risk (RR) is estimated by the HR (20). We
Figure 1 SCD Incidence Rates
(A) Sudden cardiac death (SCD) incidence rates and 95% confidence intervals (un
group, race, and disease status. (B) Age-standardized SCD incidence rates and 9calculated p trend values by creating a new variable in themultivariable model that assigned the category median to
each participant. The Wald p value was used for trend. We
verified the proportional hazards assumption by including
log(time)  exposure cross-product terms in our models
(for covariates that we did not model to vary with time). All
ed)—crude overall incidence rate as well as crude rates according to age
fidence intervals—using the 2000 U.S. Census. MI  myocardial infarction.adjust
5% condata analyses were conducted with SAS (version 9.2; SAS
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approved by the institutional review boards of all collabo-
rating institutions, and all subjects gave informed consent.
Results
After a mean follow-up time of 10.8 (SD 2.8) years, 418
women experienced SCD. The incidence rate of SCD was
2.4/10,000 women/year in this cohort of post-menopausal
women (95% CI: 2.2 to 2.7) (Fig. 1A). The incidence rate of
SCD was 4.3/10,000 women/year among African Americans
(95% CI: 3.2 to 5.4) compared with 2.3 for whites (95% CI:
2.1 to 2.6). Although the incidence rate was higher among
participants with a history of MI or heart failure, there did not
seem to be any additive or multiplicative interaction for the
effect of MI and heart failure combined (Figs. 1A and 1B).
Rates were similar when adjusted for age (Fig. 1B).
Those who experienced SCD were older, more likely to
be African American, had a lower income, smoked, and
were less educated (Table 1). Those who experienced SCD
also had a higher waist-to-hip ratio, BMI, resting pulse,
WBC, and were less active. The following medical condi-
tions were more common among participants who experi-
enced SCD: diabetes, hypercholesterolemia, hypertension,
stroke, MI, CHD, heart failure, CABG, PTCA, atrial
fibrillation, angina, and peripheral arterial disease. Several
drugs were used more often among those who experienced
SCD: aspirin, lipid-lowering medications, blood pressure
medications, and diabetes medications. Current hormone
use was less common among those who experienced SCD
compared with those who did not.
In our multivariable analysis (Table 2), the following were
independently associated with increased risk of SCD in
post-menopausal women: older age, African-American
race, smoking, higher resting pulse, higher waist-to-hip
ratio, WBC above 6.7 Kcell/ml (top 25% of the population),
and a history of the following medical conditions/diseases:
heart failure, diabetes, MI, carotid artery disease, and
hypertension. Lower income, higher BMI, and history of
atrial fibrillation were also associated with an increased risk
of SCD; however, these associations were not statistically
significant. Population-attributable fractions were 22% for
hypertension, 15% for waist-to-hip ratio 0.87, 14% for
MI, 11% for WBC above 6.7 Kcell/ml, 8% for smoking, 8%
SCD Population-Attributable FractionsTable 4 SCD Population-Attributable Fractions
Hypertension 21.5%
Waist-to-hip ratio 0.87 15.3%
MI 13.7%
WBC 6.7 Kcell/ml 10.7%
Current smoker 8.1%
Heart failure 7.5%
Diabetes 3.6%
Abbreviations as in Table 1.for heart failure, and 4% for diabetes (Table 4). eWe conducted a sensitivity analysis by excluding participants
with a history of CHD (including MI) at any time before SCD
(Table 3). The results were very similar, except that African-
American race was no longer a statistically significant indepen-
dent risk factor, and resting pulse no longer seemed to be
associated with risk of SCD. The remaining risk factors had a
slightly larger magnitude of effect.
We additionally tested the effect of the 3 WHI interventions
on risk of SCD in the clinical trial cohorts. None of the 3
interventions was associated with risk of SCD: HR: 1.04, 95%
CI: 0.69 to 1.56 for the calcium and vitamin D supplement
intervention versus control; HR: 0.94, 95% CI: 0.65 to 1.37 for
the low-fat diet intervention versus control; HR: 0.90, 95% CI:
0.51 to 1.60 for the estrogen-alone intervention versus control;
and HR: 0.61, 95% CI: 0.32 to 1.14 for the estrogen plus
progestin intervention versus control. However, the CIs are
wide and do not rule out the possibility of effects in 1 or both
directions, especially for the estrogen plus progesterone analysis
in which there were only 16 cases of SCD in the intervention
group and 25 in the control group.
We also ran a model that included all 43 potential risk
factors that were crudely associated with risk of sudden
cardiac death (p value  0.2). We additionally included—
besides factors included in Tables 2 and 3—alcohol; multi-
itamin use; physical activity; maternal history of MI;
arital status; education; systolic blood pressure; hormone
se; time of menopause; having a current care provider;
ptimism construct score; hostility construct score; whether
r not the participant was using the following drugs: aspirin,
ipid-lowering drugs, steroids, antidepressants, any antihy-
ertensive agents, beta-blockers, diuretics, angiotensin-
onverting enzyme inhibitors/angiotensin receptor blockers,
r calcium channel blockers; and participant history of the
ollowing medical conditions: high cholesterol, stroke/
ransient ischemic attack, cardiac catheterization, peripheral
rtery disease, rheumatoid arthritis, deep vein thrombosis/
ulmonary embolism, lupus, and migraines. None of these
isk factors reached statistical significance.
iscussion
ur results suggest that MI, heart failure, current cigarette
moking, diabetes, hypertension, and abdominal obesity
ight be major risk factors for SCD in women. African-
merican women had a 60% increased risk of SCD in this
tudy population even after all known risk factors and
ociodemographic factors were accounted for. Although MI
as the strongest risk factor for SCD, hypertension was
ssociated with a larger population-attributable fraction,
ikely because of its high prevalence in this population
Table 4). We found that approximately one-half of SCD
ictims were not diagnosed with CHD before death, which
s consistent with previous research (9).
Our estimated rate of SCD in post-menopausal women
2.4/10,000/year) is much lower than that reported by Zipes
t al. (7) (10 to 30/10,000/year). This might be a result of
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healthier on average than post-menopausal women in gen-
eral. However, our estimate might be more accurate and
specific than prior estimates, which would result in a lower
estimated rate (21). Zipes et al. (7) defined SCDs as deaths
from ischemic heart disease that occurred at home or in the
emergency room. This definition is more sensitive/inclusive,
which might partly explain the higher estimated rate.
Currently, it is difficult to find a valid estimate of the rate
of SCD in post-menopausal women, because of a lack of
good quality data and varied definitions. Our definition of
SCD (also called sudden cardiac arrest) is close to that used
by the Nurses’ Health Study (22), which also uses a 1-h
limit but excludes non-arrhythmic deaths. Other studies,
including the Cardiovascular Health Study, do not use a
specific time frame and instead define sudden cardiac death
as “sudden pulseless condition of cardiac origin in a previ-
ously stable individual that occurred out of the hospital or in
the emergency department” (23).
Waist-to-hip ratio, a measure of body fat distribution,
seemed to be a more important risk factor for SCD than
BMI in this cohort of post-menopausal women. Because
abdominal fat has a greater influence on inflammation than
fat stored in other areas of the body, this might mean that
inflammation plays a role in the etiology of SCD. Indeed,
we saw a positive association between WBC, a broad
measure of inflammation, and risk of SCD. Furthermore,
smoking, diabetes, and hypertension were associated with
increased risk of SCD, and these conditions are all
associated with chronic inflammation (24). Some previ-
ous research also suggests a role of inflammation (24),
where decreasing levels of albumin and increasing WBC
was associated with an increased risk of SCD. Future
studies should explore the association between other
measures of inflammation such as C-reactive protein and
other comorbid inflammatory diseases such as metabolic
syndrome and gout, and risk of SCD.
Previous studies have also found that hypertension
(10,25–28), smoking (10,25–28), heart rate (10,29,30), and
African-American race (31,32) are risk factors for SCD in
women. Although atrial fibrillation was not a statistically
significant independent risk factor in our study, unlike
others (25,27), we did see that it was associated with
increased risk of SCD. The lack of statistical significance of
this association could be due to measurement error, because
participants self-reported a history of atrial fibrillation, and
this information was collected at baseline only. Many
studies also report that diabetes or glucose intolerance is a
risk factor (25,28,33–36), yet other large longitudinal co-
horts do not find this association (1), and interestingly,
studies limited to men also do not find an association with
diabetes or glucose intolerance (37,38). Albert et al. (28)
similarly found a strong effect of MI, but most studies do
not separate CHD from MI. The fact that CHD excluding
MI is no longer an independent risk factor might mean thatMI is the key component of CHD that is associated with an
increased risk of SCD.
Unlike some studies, ours did not find that regular
exercise (39–41), family history of CHD (27,28,42), hy-
percholesterolemia (26,27), obesity (25,28), or use of drugs
that prolong the QT interval (35) were risk factors for SCD.
This is likely because other risk factors considered capture
the same pathway, for example waist-to-hip ratio and BMI.
We also found that several risk factors for acute cardiac
events were not independently associated with risk of SCD
in this cohort, including dyslipidemia, aspirin or antidepres-
sant use, hostility, and history of stroke, deep vein throm-
bosis, or pulmonary embolism. Differences between our
study findings and others might be due to differences in
underlying type of SCD. For example a higher proportion
of SCDs caused by MI in 1 study versus another might
result in a different set of risk factors that are important.
Unfortunately, we do not have information on the under-
lying cause of SCD (arrhythmia, ventricular tachycardia,
MI, stroke, and so forth), which makes it difficult to study
the underlying mechanism.
Ours is 1 of the largest studies of SCD in women drawn
from multiple ethnic groups and multiple geographic sites in
the United States. Other strengths are its prospective
design; physician-adjudicated outcomes including SCD,
MI, CABG, PTCA, angina, and carotid artery disease; and
excellent data on measured blood pressure and medication
use. We also have comprehensive data on several sociode-
mographic, physiological, traditional, medical, and behav-
ioral risk factors. Finally, we are the first to compare
population-attributable fractions between major risk factors
and to report an incidence rate for SCD in this population
on the basis of a prospective study, with a specific definition,
and with adjudicated cases of SCD.
Study limitations. The major limitation of our study is its
observational nature, which can lead to residual confound-
ing. Another important limitation is our lack of data on
subtype of SCD, which would give us more insight about
underlying mechanisms. However, our strict interpretation
of the 60-min limit and requirement for documentation of
timing within the case records provides additional rigor in
our assessment of SCD. Some deaths coded as SCDs
might actually be due to other causes, for example,
cerebral hemorrhage, acute pulmonary embolism or aortic
rupture, but these cases will also be present in any study
of sudden death in a population.
Conclusions
We found that traditional CHD risk factors likely play an
important role in the etiology of SCD in post-menopausal
women. We also found evidence that the incidence rate of
SCD in post-menopausal women might be lower than
previously estimated. Future research should look into
why African-American race was associated with a 61%
increased risk of SCD even after adjusting for age,
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tion, diet, genes, and gene– environment interaction are
all important areas for future research in discovering the
etiology of SCD.
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